1.Vascular Response of Isolated Rat Thoracic Aorta after Chemical Hypoxia/Reoxygenation.
Byong Soo JANG ; In Kyeom KIM ; Dong Gun LIM
Korean Journal of Anesthesiology 2006;50(6):698-705
BACKGROUND: Hypoxia/reoxygenation (H/R) results in formation of toxic reactive oxygen species (ROS), which can impair the vascular pathophysiology. Nitric oxide (NO) is an important free radical in many physiological or pathological processes including H/R injury. The loss of NO after H/R might be one of the major causes of an impaired vascular response. METHODS: Isolated rat aortic rings were prepared and NaCN was used to induce chemical hypoxia. The NaCN concentration and the hypoxia/reoxygenation time were determined by the responsiveness of phenylephrine (Phe), sodium nitroprusside (SNP) and acetylcholine (Ach). A cumulative doses of Phe and SNP (10(-9)-10(-5.5) M) were added to construct the vascular contraction and relaxation curves. The cumulative doses of Ach (10(-9)-10(-5) M) were added to construct the relaxation after precontraction with Phe (10(-6) M). The effects of the N(G)-nitro-L-arginine methyl ester (L-NAME, 10(-4) M) and the superoxide dismutase (SOD, 50 unit) pretreatment during chemical H/R were evaluated. RESULTS: The NaCN concentration and H/R time were 1 mM, 30 minutes/5 minutes, respectively. Chemical hypoxia reduced the Phe-induced vascular contraction significantly. However chemical H/R increased the Phe-induced contraction significantly, and impaired the relaxation by SNP and Ach. A pretreatment with L-NAME increased the Phe-induced contraction and impaired the relaxation by SNP as well as Ach. The SOD pretreatment reduced the Phe-induced increased vascular contraction after NaCN-induced chemical H/R. CONCLUSIONS: NO plays a key role in endothelial-dependent relaxation and the recovery of the augmented contractility by vasoconstrictors after chemically-induced H/R.
Acetylcholine
;
Animals
;
Anoxia
;
Aorta, Thoracic*
;
NG-Nitroarginine Methyl Ester
;
Nitric Oxide
;
Nitroprusside
;
Pathologic Processes
;
Phenylephrine
;
Rats*
;
Reactive Oxygen Species
;
Relaxation
;
Superoxide Dismutase
;
Vasoconstrictor Agents
2.Unusual Capnography due to Incorrect Assembly of Spring with Absorber Valve into Breathing Circuit - Experience of Normocarbia: A Case Report.
Byong Soo JANG ; Chang Gyu HAN ; Dong Gun LIM
The Korean Journal of Critical Care Medicine 2006;21(1):63-68
A focus on patient safety has heightened the awareness of pateint mornitoring. The importantce of clinical application of capnography continues to grow, as reflected by the increasing number of medical societies recommending its use. We recently encountered an abnormal capnography undergoing gastrectomy. It was noted that the waveform was not sustained zero-baseline formation as seen during inspiratory phase, immediately upsloping for expiratory plateau followed by inspiratoy downsloping as like a shape of curare cleft. But PaCO2 was within normal range. We found that the source of the problem was the incorrect (bottom up) assembly of spring with absorber valve into the CUBE, the circle breathing system of Dameca Ventilator. Spring with absorber valve divides CUBE circle into inspiratory and expiratory space. We concluded that the unusual capnography was resulted from the incorrect assembly of it, subsequently mixing of inspiratory and exhaled gases and rebreathing was occurred with the block of a gas flow to CO2 canister. After correcting assembly, the capnography was normalized.
Capnography*
;
Curare
;
Gases
;
Gastrectomy
;
Patient Safety
;
Reference Values
;
Respiration*
;
Societies, Medical
;
Ventilators, Mechanical
3.Estimation of CyberKnife Respiratory Tracking System Using Moving Phantom.
Jae Hyuk SEO ; Young Nam KANG ; Ji Sun JANG ; Hun Joo SHIN ; Ji Young JUNG ; Byong Ock CHOI ; Ihl Bohng CHOI ; Dong Joon LEE ; Soo Il KWON ; Jong Soo LIM
Korean Journal of Medical Physics 2009;20(4):324-330
In this study, we evaluated accuracy and usefulness of CyberKnife Respiratory Tracking System (SynchronyTM, Accuray, USA) about a moving during stereotactic radiosurgery. For this study, we used moving phantom that can move the target. We also used Respiratory Tracking System called Synchrony of the Cyberknife in order to track the moving target. For treatment planning of the moving target, we obtained an image using 4D-CT. To measure dose distribution and point dose at the moving target, ion chamber (0.62 cc) and gafchromic EBT film were used. We compared dose distribution (80% isodose line of prescription dose) of static target to that of moving target in order to evaluate the accuracy of Respiratory Tracking System. We also measured the point dose at the target. The mean difference of synchronization for TLS (target localization system) and Synchrony were 11.5+/-3.09 mm for desynchronization and 0.14+/-0.08 mm for synchronization. The mean difference between static target plan and moving target plan using 4D CT images was 0.18+/-0.06 mm. And, the accuracy of Respiratory Tracking System was less 1 mm. Estimation of usefulness in Respiratory Tracking System was 17.39+/-0.14 mm for inactivity and 1.37+/-0.11 mm for activity. The mean difference of absolute dose was 0.68+/-0.38% in static target and 1.31+/-0.81% in moving target. As a conclusion, when we treat about the moving target, we consider that it is important to use 4D-CT and the Respiratory Tracking System. In this study, we confirmed the accuracy and usefulness of Respiratory Tracking System in the Cyberknife.
Four-Dimensional Computed Tomography
;
Prescriptions
;
Radiosurgery
;
Track and Field
4.Guidelines for Video Capsule Endoscopy: Emphasis on Crohn's Disease.
Soo Kyung PARK ; Byong Duk YE ; Kyeong Ok KIM ; Cheol Hee PARK ; Wan Sik LEE ; Byung Ik JANG ; Yoon Tae JEEN ; Myung Gyu CHOI ; Hyun Jung KIM
Clinical Endoscopy 2015;48(2):128-135
Video capsule endoscopy (VCE) is an ingestible video camera that transmits high-quality images of the small intestinal mucosa. This makes the small intestine more readily accessible to physicians investigating the presence of small bowel disorders, such as Crohn's disease (CD). Although VCE is frequently performed in Korea, there are no evidence-based guidelines on the appropriate use of VCE in the diagnosis of CD. To provide accurate information and suggest correct testing approaches for small bowel diseases, the Korean Gut Image Study Group, part of the Korean Society of Gastrointestinal Endoscopy, developed guidelines on VCE. Teams were set up to develop guidelines on VCE. Four areas were selected: diagnosis of obscure gastrointestinal bleeding, small bowel preparation for VCE, diagnosis of CD, and diagnosis of small bowel tumors. Three key questions were selected regarding the role of VCE in CD. In preparing these guidelines, a systematic literature search, evaluation, selection, and meta-analysis were performed. After writing a draft of the guidelines, the opinions of various experts were solicited before producing the final document. These guidelines are expected to play a role in the diagnosis of CD. They will need to be updated as new data and evidence become available.
Capsule Endoscopy*
;
Crohn Disease*
;
Diagnosis
;
Endoscopy, Gastrointestinal
;
Hemorrhage
;
Intestinal Mucosa
;
Intestine, Small
;
Korea
;
Writing
5.Uric Acid as a Predictor of Severe Intraventricular Hemorrhage in Very Low Birth Weight Infants.
Seon Bong KIM ; Seong Hee OH ; Hyun Jeong DO ; Hee Jin JANG ; Jong Hyun YOON ; Byong Sop LEE ; Ki Soo KIM ; Ellen Ai Rhan KIM
Neonatal Medicine 2015;22(1):34-39
PURPOSE: To determine whether serum uric acid levels in the first 7 days of life can predict development of severe intraventricular hemorrhage (IVH) among very low birth weight (VLBW) infants. METHODS: VLBW infants admitted to the neonatal intensive care unit of Asan Medical Center between January 2009 and December 2012 were selected for chart review. Infants were divided into groups with and without severe IVH (grade> or =3). To determine whether uric acid is a predictor of severe IVH, uric acid levels on the first day (within 24 hours of birth), peak uric acid levels (during the first 7 days for infants without severe IVH, prior to IVH documentation by cranial sonogram for infants with severe IVH, and trend in uric acid levels were analyzed for both groups. Various antenatal and postnatal factors were compared between the groups, and risk factors associated with severe IVH were identified. RESULTS: A total of 397 VLBW infants were included, with mean birth weight of 1,075+/-292 g and a mean gestational age of 29.6+/-3.3 weeks. Higher levels of uric acid on day 1, higher peak levels, and rising uric acid levels were all found to be associated with the development of severe IVH on univariate analysis. Multivariate analysis confirmed that rising uric acid levels predicted subsequent development of severe IVH. Other factors associated with development of severe IVH included higher sodium, higher potassium, higher PaCO2, higher lactic acid, and lower PaO2. CONCLUSION: Careful attention to uric acid levels, which are easily measured, may be useful in predicting subsequent development of severe IVH among VLBW infants.
Birth Weight
;
Chungcheongnam-do
;
Gestational Age
;
Hemorrhage*
;
Humans
;
Infant*
;
Infant, Newborn
;
Infant, Very Low Birth Weight*
;
Intensive Care, Neonatal
;
Lactic Acid
;
Multivariate Analysis
;
Potassium
;
Risk Factors
;
Sodium
;
Uric Acid*
6.Case of mucinous adenocarcinoma of the lung associated with congenital pulmonary airway malformation in a neonate
Juneyoug KOH ; Euiseok JUNG ; Se Jin JANG ; Dong Kwan KIM ; Byong Sop LEE ; Ki Soo KIM ; Ellen Ai-Rhan KIM
Korean Journal of Pediatrics 2018;61(1):30-34
Congenital pulmonary airway malformation (CPAM), previously known as congenital cystic adenomatoid malformation, is a rare developmental lung abnormality associated with rhabdomyosarcoma, pleuropulmonary blastoma, and mucinous adenocarcinoma of the lung. We report an unusual case of a 10-day-old male newborn with a left lower lobe pulmonary cyst who underwent lobectomy, which revealed type II CPAM complicated by multifocal mucinous adenocarcinoma. KRAS sequencing revealed a somatic mutation in Codon12 (GGT → GAT), suggesting the development of a mucinous adenocarcinoma in the background of mucinous metaplasia. Mucinous adenocarcinoma is the most common lung tumor associated with CPAM, but it generally occurs in older children and adults. Further, all cases in the literature are of type I CPAM. This case in a neonate indicates that malignant transformation can occur very early in type II CPAM.
Adenocarcinoma, Mucinous
;
Adult
;
Child
;
Cystic Adenomatoid Malformation of Lung, Congenital
;
Humans
;
Infant, Newborn
;
Lung
;
Male
;
Metaplasia
;
Mucins
;
Rhabdomyosarcoma
7.Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study.
You Sun KIM ; Young Ho KIM ; Joo Sung KIM ; Seong Yeon JEONG ; Soo Jeong PARK ; Jae Hee CHEON ; Byong Duk YE ; Sung Ae JUNG ; Young Sook PARK ; Chang Hwan CHOI ; Kyeung Ok KIM ; Byung Ik JANG ; Dong Soo HAN ; Suk Kyun YANG ; Won Ho KIM
Gut and Liver 2014;8(6):643-647
BACKGROUND/AIMS: Cytomegalovirus (CMV) reactivations are frequently observed in patients with active ulcerative colitis (UC), and ganciclovir therapy is effective in patients with steroid-refractory UC. This study aimed to determine the long-term outcomes of CMV reactivation and the long-term therapeutic efficacy of ganciclovir treatment. METHODS: This retrospective multicenter study included a cohort of 72 patients with moderate-to-severe UC who were evaluated for CMV reactivation at the time of their initial UC flare. Colectomy, disease relapse, and the recurrence rate of CMV reactivation were investigated. RESULTS: The mean duration of follow-up for the 72 patients was 43.16+/-19.78 months (range, 1 to 67 months). The cumulative colectomy (log-rank, p=0.025) and disease flare-up rates (log-rank, p=0.048) were significantly higher in the CMV-positive group. Of the 11 patients who were successfully treated with ganciclovir in the initial treatment, three patients (27.3%) experienced CMV reactivation, and six patients (54.5%) experienced poor outcomes, such as the need for colectomy or a steroid-dependent state. CONCLUSIONS: The patients who had CMV-reactivated UC showed poor outcomes at the long-term follow-up, and the long-term efficacy of ganciclovir therapy was marginal. Careful assessment is necessary for patients who exhibit evidence of CMV reactivation.
Antiviral Agents/*therapeutic use
;
Case-Control Studies
;
Cohort Studies
;
Colectomy/utilization
;
Colitis, Ulcerative/complications/*drug therapy
;
*Cytomegalovirus
;
Cytomegalovirus Infections/complications/*drug therapy
;
Ganciclovir/*therapeutic use
;
Humans
;
Longitudinal Studies
;
Remission Induction
;
Retrospective Studies
;
Severity of Illness Index
;
Treatment Outcome
;
*Virus Activation
8.Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
Ji Min LEE ; Shu-Chen WEI ; Kang-Moon LEE ; Byong Duk YE ; Ren MAO ; Hyun-Soo KIM ; Soo Jung PARK ; Sang Hyoung PARK ; Eun Hye OH ; Jong Pil IM ; Byung Ik JANG ; Dae Bum KIM ; Ken TAKEUCHI
Gut and Liver 2022;16(3):396-403
Background/Aims:
Little is known about the clinical course of hepatitis B virus (HBV)-infected patients undergoing anti-tumor necrosis factor α (TNF-α) therapy for inflammatory bowel disease (IBD). We aimed to investigate the clinical course of HBV infection and IBD and to analyze liver dysfunction risks in patients undergoing anti-TNF-α therapy.
Methods:
This retrospective multinational study involved multiple centers in Korea, China, Tai-wan, and Japan. We enrolled IBD patients with chronic or resolved HBV infection, who received anti-TNF-α therapy. The patients’ medical records were reviewed, and data were collected using a web-based case report form.
Results:
Overall, 191 patients (77 ulcerative colitis and 114 Crohn’s disease) were included, 28.3% of whom received prophylactic antivirals. During a median follow-up duration of 32.4 months, 7.3% of patients experienced liver dysfunction due to HBV reactivation. Among patients with chronic HBV infection, the proportion experiencing liver dysfunction was significantly higher in the non-prophylaxis group (26% vs 8%, p=0.02). Liver dysfunction occurred in one patient with resolved HBV infection. Antiviral prophylaxis was independently associated with an 84% reduction in liver dysfunction risk in patients with chronic HBV infection (odds ratio, 0.16; 95% confidence interval, 0.04 to 0.66; p=0.01). The clinical course of IBD was not associated with liver dysfunction or the administration of antiviral prophylaxis.
Conclusions
Liver dysfunction due to HBV reactivation can occur in HBV-infected IBD patients treated with anti-TNF-α agents. Careful monitoring is needed in these patients, and antivirals should be administered, especially to those with chronic HBV infection.
9.Continuous Renal Replacement Therapy in the Neonatal Intensive Care Unit: A Single-Center Study.
Moon Yeon OH ; Byong Sop LEE ; Seong Hee OH ; Hee Jin JANG ; Hyun Jeong DO ; Ellen Ai Rhan KIM ; Ki Soo KIM ; Joo Hoon LEE ; Young Seo PARK ; Beom Hee LEE ; Han Wook YOO
Neonatal Medicine 2014;21(4):244-250
PURPOSE: Continuous renal replacement therapy (CRRT) has become an essential modality for the care of critically ill pediatric patients who require renal support. However, experience with CRRT in the neonatal population is not common in Korea. In this study, we aimed to investigate the clinical features, outcomes, and complications of CRRT in neonates in a single neonatal intensive care unit (NICU). METHODS: We reviewed the medical records of 17 neonates who underwent CRRT at a NICU of a tertiary hospital. The data included demographic characteristics, diagnosis, complications, and laboratory and CRRT parameters. RESULTS: The median age at initiation of CRRT was 6 days after birth. All patients were treated with CRRT in continuous venovenous hemodiafiltration mode, with a median treatment duration of 57 hours. The main indication for CRRT was an inborn error of metabolism (IEM), followed by congenital renal disease and multiorgan failure. In patients with an IEM, the median plasma ammonia level at the CRRT initiation was 1,232 micromol/L, and the mean duration until the ammonia level decreased to half of the peak ammonia level was 7.3+/-2.5 hours. The overall hospital mortality rate was 41.2%. The outcomes of the 10 survivors after discharge included death (n=2), loss to follow-up (n=3), and survival with developmental delay (n=4). CONCLUSION: Although CRRT was effective in lowering the plasma ammonia level of neonates with IEM, the associated mortality and morbidity were high. Hence, further studies are needed to optimize the CRRT protocol and to establish an effective patient referral system in Korea.
Ammonia
;
Critical Illness
;
Diagnosis
;
Follow-Up Studies
;
Hemodiafiltration
;
Hospital Mortality
;
Humans
;
Hyperammonemia
;
Infant, Newborn
;
Intensive Care, Neonatal*
;
Korea
;
Medical Records
;
Metabolism
;
Metabolism, Inborn Errors
;
Mortality
;
Parturition
;
Plasma
;
Referral and Consultation
;
Renal Replacement Therapy*
;
Survivors
;
Tertiary Care Centers
10.Seizure Scoring System and Neurodevelopmental Outcomes in Very Low Birth Weight Infants with Neonatal Seizures.
Hyun Jin KIM ; Byong Sop LEE ; Mi Sun YUM ; Hee Jin JANG ; Sung Hee OH ; Hyun Jung DO ; Sung Hoon CHUNG ; Tae Sung KO ; Ellen Ai Rhan KIM ; Ki Soo KIM
Neonatal Medicine 2013;20(4):428-437
PURPOSE: To evaluate the utility of seizure scoring system in the prediction of neurodevelopmental outcomes in very low birth weight (VLBW) infants who presented with neonatal seizures. METHODS: A retrospective review was performed in VLBW infants who were treated with antiepileptic drugs (AED) for the control of neonatal seizures. A total of 25 infants who survived and were followed-up for at least 2 years of age were included. A new seizure scoring system (the composite score 0-8) was constructed by choosing the following variables: onset, response to the AED, presence of status epilepticus, seizure types and EEG findings including background activity and epileptiform discharges. Neurodevelopmental outcomes were graded from 1 to 5 based on the developmental status and the neurologic abnormalities assessed at 18 to 24 months of postconceptional age. Risk factor analyses for predicting unfavorable outcomes (grade 3-5) versus favorable outcomes (grade 1-2) were performed. RESULTS: Compared to favorable outcome group (n=11), unfavorable outcome group (n=14) had higher incidence of subtle or generalized tonic-type seizures, the abnormal EEG background activity and poor response to AED. The composite seizure score was significantly higher in the unfavorable outcome group (3.2+/-0.7) than in the favorable outcome group (1.2+/-1.2) and it significantly correlated with the neurodevelopmental grading (P<0.001). In multivariate analysis, abnormal MRI findings at term and the composite seizure score were significant risk factors for unfavorable outcomes. CONCLUSION: In VLBW infants with neonatal seizure, the proposed seizure scoring system was a simple and useful predictor of long-term neurologic outcomes.
Anticonvulsants
;
Electroencephalography
;
Humans
;
Incidence
;
Infant*
;
Infant, Very Low Birth Weight*
;
Magnetic Resonance Imaging
;
Multivariate Analysis
;
Retrospective Studies
;
Risk Factors
;
Seizures*
;
Status Epilepticus